Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD

被引:6
作者
Aleya, Walid Ben [1 ]
Sfar, Imen [1 ]
Mouelhi, Leila [2 ]
Aouadi, Houda [1 ]
Makhlouf, Mouna [1 ]
Ayed-Jendoubi, Salwa [1 ]
Matri, Samira [2 ]
Filali, Azza [2 ]
Najjar, Taoufik [2 ]
Ben Abdallah, Taeib [1 ]
Ayed, Khaled [1 ]
Gorgi, Yousr [1 ]
机构
[1] EPS Charles Nicolle, Immunol Lab, Tunis 1006, Tunisia
[2] EPS Charles Nicolle, Dept Gastroenterol, Tunis 1006, Tunisia
关键词
Fas/Apo1; Gene polymorphisms; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ULCERATIVE-COLITIS; FAS LIGAND; MULTIPLE-SCLEROSIS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; EPITHELIAL-CELLS; APOPTOSIS; EXPRESSION;
D O I
10.3748/wjg.15.3643
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To detect a possible association between the polymorphism of the (-670 A/G) Fas/Apo1 gene promoter and susceptibility to Crohn's disease (CD) and ulcerative colitis (UC) in the Tunisian population. METHODS: The (-670 A/G) Fas polymorphism was analyzed in 105 patients with CD, 59 patients with UC, and 100 controls using the polymerase chain reaction restriction fragment length polymorphism method. RESULTS: Significantly lower frequencies of the Fas -670 A allele and A/A homozygous individuals were observed in CD and UC patients when compared with controls. Analysis of (-670 A/G) Fas polymorphism with respect to sex in CD and UC showed a significant difference in A/A genotypes between female patients and controls (P corrected = 0.004 "in CD patients" and P corrected = 0.02 "in UC patients", respectively). Analysis also showed a statistically significant association between genotype AA of the (-670 A/G) polymorphism and the ileum localization of the lesions (P corrected = 0.048) and between genotype GG and the colon localization (P corrected = 0.009). The analysis of IBD patients according to clinical behavior revealed no difference. CONCLUSION: Fas-670 polymorphism was associated with the development of CD and UC in the Tunisian population. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:3643 / 3648
页数:6
相关论文
共 41 条
  • [1] Review Article: The genetics of inflammatory bowel disease
    Ahmad, T
    Satsangi, J
    Mcgovern, D
    Bunce, M
    Jewell, DP
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (06) : 731 - 748
  • [2] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [3] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [4] Bolstad AI, 2000, J RHEUMATOL, V27, P2397
  • [5] NITRIC-OXIDE SYNTHASE ACTIVITY IN ULCERATIVE-COLITIS AND CROHNS-DISEASE
    BOUGHTONSMITH, NK
    EVANS, SM
    HAWKEY, CJ
    COLE, AT
    BALSITIS, M
    WHITTLE, BJR
    MONCADA, S
    [J]. LANCET, 1993, 342 (8867) : 338 - 340
  • [6] Apoptosis: One of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system
    Bu, P
    Keshavarzian, A
    Stone, DD
    Liu, JZ
    Le, PT
    Fisher, S
    Qiao, L
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 6399 - 6403
  • [7] Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection
    Cascino, I
    Ballerini, C
    Audino, S
    Rombolà, G
    Massacesi, L
    Colombo, G
    Smeraldi, RS
    D'Alfonso, S
    Richiardi, PM
    Tosi, R
    Ruberti, G
    [J]. DISEASE MARKERS, 1998, 13 (04) : 221 - 225
  • [8] Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes - A potential role for the acidic sphingomyelinase pathway in normal immunoregulation
    DeMaria, R
    Boirivant, M
    Cifone, MG
    Roncaioli, P
    Hahne, M
    Tschopp, J
    Pallone, F
    Santoni, A
    Testi, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) : 316 - 322
  • [9] Inflammatory bowel disease: Etiology and pathogenesis
    Fiocchi, C
    [J]. GASTROENTEROLOGY, 1998, 115 (01) : 182 - 205
  • [10] IL-1β converting enzyme is a target for nitric oxide-releasing aspirin:: New insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs
    Fiorucci, S
    Santucci, L
    Cirino, G
    Mencarelli, A
    Familiari, L
    Del Soldato, P
    Morelli, A
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 5245 - 5254